TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ytterby Life Science AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,376
|
1,258
|
1,071 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
343
![]() |
343
|
291 |
EBITDA |
231
|
243
|
246 |
Total assets |
611
|
543
|
392 |
Current assets |
581
|
513
|
362 |
Current liabilities |
58
|
53
|
44 |
Equity capital |
496
|
448
|
320 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
81.2%
|
82.5%
|
81.6% |
Turnover per employee |
1,376
|
1,258
|
1,071 |
Profit as a percentage of turnover |
24.9%
|
27.3%
|
27.2% |
Return on assets (ROA) |
56.1%
|
63.2%
|
74.2% |
Current ratio |
1001.7%
|
967.9%
|
822.7% |
Return on equity (ROE) |
69.2%
|
76.6%
|
90.9% |
Change turnover |
118
|
187
|
163 |
Change turnover % |
9%
|
17%
|
18% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.